Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAURITE 3: Corabotase in Moderate to Severe Glabellar Lines
NCT07779252Phase 3Recruiting
- Sponsor
- Ipsen
- Start
- Aug 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
A Phase 3 trial of corabotase in glabellar lines, sponsored by Ipsen. Started Aug 2026; status: recruiting.
02
Drugs
corabotase
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT07779252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07779252.